Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

RSS icon
Thumbnail

Unlocking the great cell Mediator

Using high-powered electron microscopy, scientists at the Scripps Research Institute in La Jolla, Calif., have uncovered one of the most important cellular mechanisms of gene expression, the Mediator, according to a study published today in the journal Cell. The researchers’ new map of cellular machinery is key to a deeper understanding of cellular processes, including the production of proteins.

Thumbnail

NIH presents scientific outline of BRAIN Initiative

An outline of the science resulting from the $4.5 billion funding earmarked by a recent federal report for the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative was released today by the National Institutes of Health (NIH).

Thumbnail

Meet SNMMI in St. Louis for the 2014 Annual Meeting

Saturday marks the first day of the Society of Nuclear Medicine and Molecular Imaging’s 2014 Annual Meeting being held June 7-11 at the St. Louis Convention Center. This year is the banner 60th anniversary of the SNMMI Annual Meeting, jam-packed with plenary and scientific sessions as well as an exhibition of technologies and services catered exclusively to professionals in the field of molecular imaging.

Congress shows strong support for Medicare coverage of lung cancer screening

A large number of United States Senators and Representatives are taking the lead to support full Medicare coverage of low-dose computed tomography (LDCT) screening for seniors at high risk for lung cancer.

Cerebral 18F-FDG PET may predict long-term recovery of patients in vegetative states

Cerebral 18F-FDG PET could be used to complement bedside exams and predict long-term recovery of patients with unresponsive wakefulness syndrome, according to a study published online April 15 by The Lancet.

Considering radium-223 as a treatment option

Radium-223 should be considered as a treatment option for patients with castration-resistant prostate cancer and symptomatic bone metastases, according to a study published in the June issue of the Lancet Oncology. 

Thumbnail

WMIS presents tools for IND approval

Easing FDA investigational new drug (IND) approvals for novel PET probes is the subject of a study recently published in Molecular Imaging and Biology and announced today by parent organization The World Molecular Imaging Society.

Diffusion-weighted MRI could stratify prostate cancer treatment options

Diffusion-weighted (DW)-MRI noninvasively detects significant prostate cancer with high probability without the use of contrast medium or an endorectal coil and could be used as a tool to stratify patients with prostate cancer for individualized treatment options, according to a study published online March 15 in the Journal of Urology. 

Displaying 4793 - 4800 of 23545

Around the web

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.